Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve 1. Consider and approve Audited Financial Results & Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2026.\r\n2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended 31st March, 2026.\r\n3. Consider and recommend Bonus Equity Shares subject to approval of Members of the Company.